HEADER HYDROLASE 11-APR-20 6YN8 TITLE HUMAN MALT1(334-719) IN COMPLEX WITH A TETRAZOLE CONTAINING COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION COMPND 3 PROTEIN 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MALT LYMPHOMA-ASSOCIATED TRANSLOCATION,PARACASPASE; COMPND 6 EC: 3.4.22.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MALT1, MLT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET KEYWDS DIMER, ACTIVE SITE INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR M.RENATUS REVDAT 3 24-JAN-24 6YN8 1 JRNL REVDAT 2 13-JAN-21 6YN8 1 JRNL REVDAT 1 24-JUN-20 6YN8 0 JRNL AUTH N.HUGHES,P.ERBEL,F.BORNANCIN,C.WIESMANN,N.SCHIERING, JRNL AUTH 2 F.VILLARD,A.DECOCK,B.RUBI,S.MELKKO,C.SPANKA,N.BUSCHMANN, JRNL AUTH 3 C.PISSOT-SOLDERMANN,O.SIMIC,R.BEERLI,M.SORGE, JRNL AUTH 4 M.TINTELNOT-BLOMLEY,K.BELTZ,C.H.REGNIER,J.QUANCARD, JRNL AUTH 5 A.SCHLAPBACH,J.LANGLOIS,M.RENATUS JRNL TITL STABILIZING INACTIVE CONFORMATIONS OF MALT1 AS AN EFFECTIVE JRNL TITL 2 APPROACH TO INHIBIT ITS PROTEASE ACTIVITY JRNL REF ADVANCED THERAPEUTICS V. 3 2020 JRNL REFN ESSN 2366-3987 JRNL DOI 10.1002/ADTP.202000078 REMARK 2 REMARK 2 RESOLUTION. 3.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (6-FEB-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 11243 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 547 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.05 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.09 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 391 REMARK 3 BIN R VALUE (WORKING SET) : 0.3002 REMARK 3 BIN FREE R VALUE : 0.4104 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.24 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 26 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2891 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 4 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 105.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 109.5 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -59.13640 REMARK 3 B22 (A**2) : 14.08100 REMARK 3 B33 (A**2) : 45.05550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.470 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.373 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.871 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.868 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2987 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4042 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1063 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 528 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2987 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 378 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1956 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.92 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.73 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -19.9235 -5.7631 -26.9817 REMARK 3 T TENSOR REMARK 3 T11: 0.0371 T22: -0.1684 REMARK 3 T33: -0.0506 T12: -0.1069 REMARK 3 T13: -0.0220 T23: 0.0316 REMARK 3 L TENSOR REMARK 3 L11: 0.5473 L22: 2.2228 REMARK 3 L33: 4.5903 L12: 0.0048 REMARK 3 L13: -0.1739 L23: 0.3716 REMARK 3 S TENSOR REMARK 3 S11: -0.0229 S12: -0.0455 S13: 0.0698 REMARK 3 S21: -0.5442 S22: -0.0065 S23: 0.0049 REMARK 3 S31: -0.0327 S32: -0.0806 S33: 0.0294 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YN8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-APR-20. REMARK 100 THE DEPOSITION ID IS D_1292107915. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-NOV-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99990 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 (13-DEC-2018) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11243 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.052 REMARK 200 RESOLUTION RANGE LOW (A) : 60.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 0.93500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3V55 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8 M SODIUM/POTASSIUM PHOSPHATE PH REMARK 280 6.9 10MG/ML PROTEIN IN 25MM HEPES PH7.5, 50MM NACL, 1MM TCEP. REMARK 280 MIXED WITH COMPOUND (FINAL CONCENTRATION AT 1MM), VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.64650 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.17800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.64650 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.17800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.64650 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 53.17800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.64650 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 53.17800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 901 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 331 REMARK 465 PRO A 332 REMARK 465 GLY A 333 REMARK 465 THR A 334 REMARK 465 THR A 335 REMARK 465 ASP A 336 REMARK 465 LYS A 466 REMARK 465 ARG A 467 REMARK 465 ASN A 468 REMARK 465 ASP A 469 REMARK 465 TYR A 470 REMARK 465 ASP A 471 REMARK 465 ASP A 472 REMARK 465 THR A 473 REMARK 465 ILE A 474 REMARK 465 PRO A 475 REMARK 465 ILE A 476 REMARK 465 LEU A 477 REMARK 465 ASP A 478 REMARK 465 ALA A 479 REMARK 465 LEU A 480 REMARK 465 LYS A 481 REMARK 465 HIS A 718 REMARK 465 ARG A 719 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 351 -53.51 -122.89 REMARK 500 GLU A 453 41.87 -104.75 REMARK 500 GLN A 494 104.94 -38.86 REMARK 500 ALA A 496 -49.37 167.25 REMARK 500 GLU A 500 -13.58 80.69 REMARK 500 GLN A 565 -157.60 -78.41 REMARK 500 GLU A 568 71.75 35.68 REMARK 500 ILE A 641 -74.28 -78.80 REMARK 500 ASP A 642 111.28 89.03 REMARK 500 LEU A 711 -116.95 52.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OZK A 801 DBREF 6YN8 A 334 719 UNP Q9UDY8 MALT1_HUMAN 334 719 SEQADV 6YN8 GLY A 331 UNP Q9UDY8 EXPRESSION TAG SEQADV 6YN8 PRO A 332 UNP Q9UDY8 EXPRESSION TAG SEQADV 6YN8 GLY A 333 UNP Q9UDY8 EXPRESSION TAG SEQRES 1 A 389 GLY PRO GLY THR THR ASP GLN PRO LEU ALA LYS ASP LYS SEQRES 2 A 389 VAL ALA LEU LEU ILE GLY ASN MET ASN TYR ARG GLU HIS SEQRES 3 A 389 PRO LYS LEU LYS ALA PRO LEU VAL ASP VAL TYR GLU LEU SEQRES 4 A 389 THR ASN LEU LEU ARG GLN LEU ASP PHE LYS VAL VAL SER SEQRES 5 A 389 LEU LEU ASP LEU THR GLU TYR GLU MET ARG ASN ALA VAL SEQRES 6 A 389 ASP GLU PHE LEU LEU LEU LEU ASP LYS GLY VAL TYR GLY SEQRES 7 A 389 LEU LEU TYR TYR ALA GLY HIS GLY TYR GLU ASN PHE GLY SEQRES 8 A 389 ASN SER PHE MET VAL PRO VAL ASP ALA PRO ASN PRO TYR SEQRES 9 A 389 ARG SER GLU ASN CYS LEU CYS VAL GLN ASN ILE LEU LYS SEQRES 10 A 389 LEU MET GLN GLU LYS GLU THR GLY LEU ASN VAL PHE LEU SEQRES 11 A 389 LEU ASP MET CYS ARG LYS ARG ASN ASP TYR ASP ASP THR SEQRES 12 A 389 ILE PRO ILE LEU ASP ALA LEU LYS VAL THR ALA ASN ILE SEQRES 13 A 389 VAL PHE GLY TYR ALA THR CYS GLN GLY ALA GLU ALA PHE SEQRES 14 A 389 GLU ILE GLN HIS SER GLY LEU ALA ASN GLY ILE PHE MET SEQRES 15 A 389 LYS PHE LEU LYS ASP ARG LEU LEU GLU ASP LYS LYS ILE SEQRES 16 A 389 THR VAL LEU LEU ASP GLU VAL ALA GLU ASP MET GLY LYS SEQRES 17 A 389 CYS HIS LEU THR LYS GLY LYS GLN ALA LEU GLU ILE ARG SEQRES 18 A 389 SER SER LEU SER GLU LYS ARG ALA LEU THR ASP PRO ILE SEQRES 19 A 389 GLN GLY THR GLU TYR SER ALA GLU SER LEU VAL ARG ASN SEQRES 20 A 389 LEU GLN TRP ALA LYS ALA HIS GLU LEU PRO GLU SER MET SEQRES 21 A 389 CYS LEU LYS PHE ASP CYS GLY VAL GLN ILE GLN LEU GLY SEQRES 22 A 389 PHE ALA ALA GLU PHE SER ASN VAL MET ILE ILE TYR THR SEQRES 23 A 389 SER ILE VAL TYR LYS PRO PRO GLU ILE ILE MET CYS ASP SEQRES 24 A 389 ALA TYR VAL THR ASP PHE PRO LEU ASP LEU ASP ILE ASP SEQRES 25 A 389 PRO LYS ASP ALA ASN LYS GLY THR PRO GLU GLU THR GLY SEQRES 26 A 389 SER TYR LEU VAL SER LYS ASP LEU PRO LYS HIS CYS LEU SEQRES 27 A 389 TYR THR ARG LEU SER SER LEU GLN LYS LEU LYS GLU HIS SEQRES 28 A 389 LEU VAL PHE THR VAL CYS LEU SER TYR GLN TYR SER GLY SEQRES 29 A 389 LEU GLU ASP THR VAL GLU ASP LYS GLN GLU VAL ASN VAL SEQRES 30 A 389 GLY LYS PRO LEU ILE ALA LYS LEU ASP MET HIS ARG HET OZK A 801 38 HETNAM OZK 3-AZANYL-3-METHYL-~{N}-[(3~{R})-4-OXIDANYLIDENE-5-[[4- HETNAM 2 OZK [2-(1~{H}-1,2,3,4-TETRAZOL-5-YL)PHENYL]PHENYL]METHYL]- HETNAM 3 OZK 2,3-DIHYDRO-1,5-BENZOXAZEPIN-3-YL]BUTANAMIDE FORMUL 2 OZK C28 H29 N7 O3 FORMUL 3 HOH *4(H2 O) HELIX 1 AA1 LYS A 360 LEU A 376 1 17 HELIX 2 AA2 THR A 387 LEU A 400 1 14 HELIX 3 AA3 ARG A 435 CYS A 439 5 5 HELIX 4 AA4 VAL A 442 GLU A 451 1 10 HELIX 5 AA5 GLY A 509 ASP A 517 1 9 HELIX 6 AA6 LYS A 524 CYS A 539 1 16 HELIX 7 AA7 SER A 573 ALA A 583 1 11 HELIX 8 AA8 PRO A 636 ASP A 640 5 5 HELIX 9 AA9 ASP A 642 ALA A 646 5 5 HELIX 10 AB1 THR A 650 GLY A 655 5 6 HELIX 11 AB2 SER A 674 LEU A 678 5 5 HELIX 12 AB3 PRO A 710 LEU A 715 5 6 SHEET 1 AA1 5 LYS A 379 LEU A 384 0 SHEET 2 AA1 5 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383 SHEET 3 AA1 5 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 AA1 5 ASN A 422 MET A 425 -1 O ASN A 422 N ASN A 419 SHEET 5 AA1 5 LEU A 440 CYS A 441 -1 O LEU A 440 N MET A 425 SHEET 1 AA2 6 LYS A 379 LEU A 384 0 SHEET 2 AA2 6 LYS A 343 GLY A 349 1 N LEU A 347 O LEU A 383 SHEET 3 AA2 6 TYR A 407 ASN A 419 1 O TYR A 411 N ILE A 348 SHEET 4 AA2 6 LEU A 456 CYS A 464 1 O ASP A 462 N TYR A 412 SHEET 5 AA2 6 ILE A 486 THR A 492 1 O GLY A 489 N PHE A 459 SHEET 6 AA2 6 ALA A 547 SER A 552 -1 O ARG A 551 N PHE A 488 SHEET 1 AA3 4 MET A 590 LYS A 593 0 SHEET 2 AA3 4 GLN A 599 PHE A 608 -1 O LEU A 602 N MET A 590 SHEET 3 AA3 4 VAL A 611 TYR A 620 -1 O SER A 617 N GLN A 601 SHEET 4 AA3 4 LEU A 668 LEU A 672 -1 O LEU A 672 N MET A 612 SHEET 1 AA4 3 ILE A 625 THR A 633 0 SHEET 2 AA4 3 VAL A 683 TYR A 692 -1 O CYS A 687 N TYR A 631 SHEET 3 AA4 3 VAL A 699 ASN A 706 -1 O VAL A 699 N TYR A 690 CISPEP 1 ASN A 432 PRO A 433 0 5.75 SITE 1 AC1 14 LYS A 360 ALA A 361 ASP A 462 CYS A 493 SITE 2 AC1 14 GLY A 495 ALA A 496 PHE A 499 HIS A 503 SITE 3 AC1 14 GLY A 505 ALA A 507 ASN A 508 GLY A 509 SITE 4 AC1 14 ILE A 510 HOH A 902 CRYST1 101.293 106.356 106.455 90.00 90.00 90.00 C 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009872 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009402 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009394 0.00000